Monday, November 04, 2019 12:48:40 PM
JUSHF NEWS
BOCA RATON, Fla., Nov. 4, 2019 /PRNewswire/ -- Jushi Holdings Inc. ("Jushi" or the "Company") (NEO: JUSH.B) (OTCQX: JUSHF), a globally-focused, multi-state cannabis and hemp operator, today announced that Jushi medical leadership and management will present at two upcoming conferences:
Medical Cannabiz Summit World to be held at the InterContinental Malta hotel in Malta on November 4-5, 2019. Dr. Laszlo Mechtler, FAAN, FAEN, FASN, Medical Director of Jushi, the DENT Neurologic Institute and DENT Cannabis Clinic will present, "R&D: Inspecting the Endocannabinoid and Central Nervous System," on Tuesday, November 5, 2019 at 1:30 p.m. CET.
Bryan, Garnier & Co. Cannabis Conference to be held at The May Fair hotel in London, UK on November 28, 2019. Daniel Swasbrook, President of Jushi Europe, will present at 11:00 a.m. GMT.
For more information about the conferences, or to schedule a one-on-one meeting with Jushi's medical leadership and management during these events, please contact KCSA Strategic Communications at Jushi@kcsa.com.
About Jushi Holdings Inc.
We are a globally focused cannabis and hemp company led by an industry leading management team. In the United States Jushi is focused on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis and hemp ecosystem. For more information please visit www.jushico.com or our social media channels, Instagram, Facebook, Twitter and LinkedIn.
BOCA RATON, Fla., Nov. 4, 2019 /PRNewswire/ -- Jushi Holdings Inc. ("Jushi" or the "Company") (NEO: JUSH.B) (OTCQX: JUSHF), a globally-focused, multi-state cannabis and hemp operator, today announced that Jushi medical leadership and management will present at two upcoming conferences:
Medical Cannabiz Summit World to be held at the InterContinental Malta hotel in Malta on November 4-5, 2019. Dr. Laszlo Mechtler, FAAN, FAEN, FASN, Medical Director of Jushi, the DENT Neurologic Institute and DENT Cannabis Clinic will present, "R&D: Inspecting the Endocannabinoid and Central Nervous System," on Tuesday, November 5, 2019 at 1:30 p.m. CET.
Bryan, Garnier & Co. Cannabis Conference to be held at The May Fair hotel in London, UK on November 28, 2019. Daniel Swasbrook, President of Jushi Europe, will present at 11:00 a.m. GMT.
For more information about the conferences, or to schedule a one-on-one meeting with Jushi's medical leadership and management during these events, please contact KCSA Strategic Communications at Jushi@kcsa.com.
About Jushi Holdings Inc.
We are a globally focused cannabis and hemp company led by an industry leading management team. In the United States Jushi is focused on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis and hemp ecosystem. For more information please visit www.jushico.com or our social media channels, Instagram, Facebook, Twitter and LinkedIn.
ALL IMO
Recent JUSHF News
- Jushi Holdings Inc. Announces Applications Submitted for DEA Registration of State-Licensed Medical Cannabis Operations • GlobeNewswire Inc. • 05/28/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:26:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:05:40 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/11/2026 08:11:44 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/11/2026 08:10:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/11/2026 08:07:50 PM
- James Cacioppo Files Updated Early Warning Report • GlobeNewswire Inc. • 05/08/2026 08:05:00 PM
- Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 • GlobeNewswire Inc. • 05/04/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2026 12:30:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2026 12:30:03 PM
- Jushi Holdings Inc. Announces Proposed Continuance from British Columbia to Nevada • GlobeNewswire Inc. • 04/24/2026 12:30:00 PM
- Jushi Holdings Inc. Applauds President Trump and Administration for Delivering on Cannabis Rescheduling to Schedule III under the Controlled Substances Act • GlobeNewswire Inc. • 04/23/2026 01:43:18 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/14/2026 08:10:21 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:28:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:00:10 PM
- Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/31/2026 08:00:00 PM
- Jushi Holdings Inc. Refinances Former 1st Lien Credit Facility and Former 2nd Lien Credit Facility with US$160 Million Non-Dilutive Debt Financing • GlobeNewswire Inc. • 03/27/2026 04:03:42 PM
- Jushi Holdings Inc. Announces First Settlement in Ongoing Hemp-Derived THC Litigation • GlobeNewswire Inc. • 03/25/2026 12:39:39 PM
- Jushi Holdings Inc. Announces Grand Opening of Second Beyond Hello™ in Cincinnati, Ohio, Expanding its Statewide Retail Footprint • GlobeNewswire Inc. • 01/21/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2026 09:20:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 01:01:19 PM
- Jushi Holdings Inc. Announces Amendment to CEO Employment Agreement • GlobeNewswire Inc. • 12/16/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 11:32:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 11:27:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 11:24:32 PM
